Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach.

Genetic epidemiology - 1 Feb 2018

Moss Haley A, Samimi Goli, Havrilesky Laura J, Sherman Mark E, Myers Evan R

Abstract excerpt

U.S. guidelines recommend BRCA1/2 mutation testing for women diagnosed with high-grade ovarian cancer (HGOC) to increase recognition of carriers, but most remain unidentified and at risk. Accordingly, an approach termed "Traceback" has been proposed in which probands are retrospectively identified by testing archived pathology specimens, and family members are traced to provide genetic counseling and testing. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cause of Death

Share to Family

Share to Genes, BRCA1

Share to Genetic Counseling

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to Informed Consent

Source

Identifiers

PMID: 29193313
DOI: 10.1002/gepi.22095

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach.PMID 29193313Read ↗

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based OutreachSemantic proximity Read ↗

Genetic counseling and genetic testing for pathogenic germline mutations among high-risk patients previously diagnosed with breast cancer: a traceback approach.Semantic proximity Read ↗

TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.Semantic proximity Read ↗

Cascade testing in an ovarian cancer traceback genetic testing program: The GRACE study experience.Semantic proximity Read ↗

Genetic testing in women with early-onset breast cancer: a Traceback pilot study.Semantic proximity Read ↗

The Knowledge and Attitude of Patients Diagnosed with Epithelial Ovarian Cancer towards Genetic Testing.Semantic proximity Read ↗

Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer.Semantic proximity Read ↗

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.Semantic proximity Read ↗

Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology.Semantic proximity Read ↗

Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer.Semantic proximity Read ↗

Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?Semantic proximity Read ↗

Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.